BR9810557A - Compostos derivados de tiofeno e benzotiofeno e utilização e composição correspondentes - Google Patents

Compostos derivados de tiofeno e benzotiofeno e utilização e composição correspondentes

Info

Publication number
BR9810557A
BR9810557A BR9810557-4A BR9810557A BR9810557A BR 9810557 A BR9810557 A BR 9810557A BR 9810557 A BR9810557 A BR 9810557A BR 9810557 A BR9810557 A BR 9810557A
Authority
BR
Brazil
Prior art keywords
alkyl
thiophene
composition
benzothiophene
compounds
Prior art date
Application number
BR9810557-4A
Other languages
English (en)
Inventor
Antonio Monge Vega
Joaquin Del Rio Zambrana
Berta Lasheras Aldaz
Juan Antonio Palop Cubillo
Anna Bosch Rovira
Juan Carlos Del Catillo Nieto
Juan Roca Acin
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of BR9810557A publication Critical patent/BR9810557A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS DERIVADOS DE TIOFENO E BENZOTIOFENO E UTILIZAçãO E COMPOSIçãO CORRESPONDENTES"<D>. Compostos derivados de tiofeno e benzotiofeno e utilização e composição correspondentes; os compostos têm a fórmula (I) onde Z é -CO-CH(OR~ 6~)-, -C(NOR~ 7~)-; R~ 1~é: H, alquila C~ 1~-C~ 6~, halogênio ou -O-R~ 12~; R~ 2~ e R~ 3~ são H, alquila, halogênio, nitro ou -O-R~ 12~ ou ainda R~ 2~ e R~ 3~ juntos são -CR~ 8~=CR~ 9~-CR~ 10~=CR~ 11~-; R~ 4~ e R~ 5~ são H, alquila, halogênio, haloalquila, -OR~ 12~, nitro, -NR~ 13~R~ 14~; -COR~ 12~, -CO~ 2~R~ 12~, -SO~ 2~NR~ 13~R~ 14~, -SO~ 2~R~ 12~, -SR~ 12~, ciano, -CONR~ 13~R~ 14~, ou ainda R~ 4~e R~ 5~ juntos formam um anel benzeno; R~ 6~é: H, alquila, -CO~ 2~R~ 12~, -C(O)NR~ 13~R~ 14~, naftila ou fenila; R~ 7~é: H ou alquila; R~ 8~, R~ 9~, R~ 10~ e R~ 11~ são H, alquila, halogênio, -OR~ 12~, nitro, ciano, -NR~ 13~R~ 14~, -COR~ 12~, -CO~ 2~ R~ 12~, -SO~ 2~NR~ 13~R~ 14~, -SO~ 2~R~ 12~, -SR~ 12~, -CONR~ 13~R~ 14~; R~ 12~ é H, alquila C~ 1~-C~ 6~ ou fenila; e R~ 13~e R~ 14~ são H, alquila C~ 1~-C~ 6~ou fenila ou ainda R~ 13~ e R~ 14~um anel de 5 ou 6. Estes compostos são eficazes para o tratamento da ansiedade e da depressão.
BR9810557-4A 1997-07-08 1998-07-01 Compostos derivados de tiofeno e benzotiofeno e utilização e composição correspondentes BR9810557A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009701517A ES2128266B1 (es) 1997-07-08 1997-07-08 Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.
PCT/ES1998/000191 WO1999002516A1 (es) 1997-07-08 1998-07-01 Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes

Publications (1)

Publication Number Publication Date
BR9810557A true BR9810557A (pt) 2000-08-08

Family

ID=8299986

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810557-4A BR9810557A (pt) 1997-07-08 1998-07-01 Compostos derivados de tiofeno e benzotiofeno e utilização e composição correspondentes

Country Status (21)

Country Link
US (1) US6262056B1 (pt)
EP (1) EP1008594B1 (pt)
JP (1) JP2002511883A (pt)
KR (1) KR20010021632A (pt)
CN (1) CN1125821C (pt)
AT (1) ATE261956T1 (pt)
AU (1) AU735637B2 (pt)
BR (1) BR9810557A (pt)
CA (1) CA2295715A1 (pt)
DE (1) DE69822478D1 (pt)
EA (1) EA002687B1 (pt)
ES (1) ES2128266B1 (pt)
HU (1) HUP0002861A3 (pt)
IL (1) IL133566A (pt)
IS (1) IS5328A (pt)
NZ (1) NZ502128A (pt)
OA (1) OA11274A (pt)
PL (1) PL337930A1 (pt)
SK (1) SK272000A3 (pt)
TR (1) TR200000058T2 (pt)
WO (1) WO1999002516A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007431A2 (en) * 1999-07-21 2001-02-01 Eli Lilly And Company Benzothiophene derivatives
ATE261959T1 (de) 1999-12-30 2004-04-15 Lundbeck & Co As H Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
DE10043659A1 (de) * 2000-09-05 2002-03-14 Merck Patent Gmbh Arylpiperazinderivate
ES2188344B1 (es) * 2000-11-29 2004-09-16 Laboratorios Vita, S.A. Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
JP2006516977A (ja) 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
WO2004082686A2 (en) * 2003-03-13 2004-09-30 Dynogen Pharmaceuticals, Inc. Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
ES2379848T3 (es) * 2007-05-14 2012-05-04 Sk Biopharmaceuticals Co., Ltd. Compuesto arilpiperazina arilalcanoil carbomoiloxi novedoso, composiciones farmacéuticas que comprenden el compuesto y método para tratar el dolor, ansiedad y depresión al administrar el compuesto
CN101613347B (zh) * 2008-06-23 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物及其医药用途
CN101619056B (zh) 2008-07-02 2013-07-17 石药集团中奇制药技术(石家庄)有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
EP2539706B1 (en) * 2010-02-24 2015-03-04 Research Triangle Institute Arylpiperazine opioid receptor antagonists
EP3083589B1 (en) 2013-12-20 2019-12-18 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
WO2021152113A1 (en) 2020-01-31 2021-08-05 Bayer Aktiengesellschaft Substituted 2,3-benzodiazepines derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979507A (en) * 1959-03-26 1961-04-11 Paul Adriaan J Janssen 1-(2-thenoyl) alkyl-4-arylpiperazines
US3002976A (en) * 1959-10-12 1961-10-03 Paul A J Janssen 1-(2-thienyl)-omega-(4-arylpiperazine)alkanols
GB1096341A (en) * 1965-03-09 1967-12-29 Mauvernay Roland Yves Novel derivatives of the phenyl-piperazine series and process for their preparation
US4515793A (en) * 1983-07-27 1985-05-07 Edna Mcconnell Clark Foundation Phenylpiperazines which are useful in the treatment of schistosomiasis
WO1993003025A1 (en) * 1991-08-09 1993-02-18 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compound
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5632898A (en) * 1996-08-13 1997-05-27 Isis Pharmaceuticals, Inc. Method for removing unreacted electrophiles from a reaction mixture

Also Published As

Publication number Publication date
JP2002511883A (ja) 2002-04-16
AU735637B2 (en) 2001-07-12
KR20010021632A (ko) 2001-03-15
EA200000101A1 (ru) 2000-08-28
IL133566A0 (en) 2001-04-30
SK272000A3 (en) 2000-07-11
CA2295715A1 (en) 1999-01-21
DE69822478D1 (de) 2004-04-22
PL337930A1 (en) 2000-09-11
IL133566A (en) 2003-10-31
EP1008594B1 (en) 2004-03-17
ES2128266B1 (es) 2000-01-16
IS5328A (is) 1999-12-29
OA11274A (en) 2003-07-29
CN1125821C (zh) 2003-10-29
CN1265106A (zh) 2000-08-30
HUP0002861A3 (en) 2001-09-28
NZ502128A (en) 2001-09-28
EP1008594A1 (en) 2000-06-14
ATE261956T1 (de) 2004-04-15
AU8111398A (en) 1999-02-08
US6262056B1 (en) 2001-07-17
TR200000058T2 (tr) 2000-09-21
ES2128266A1 (es) 1999-05-01
EA002687B1 (ru) 2002-08-29
HUP0002861A2 (hu) 2001-08-28
WO1999002516A1 (es) 1999-01-21

Similar Documents

Publication Publication Date Title
BR9810557A (pt) Compostos derivados de tiofeno e benzotiofeno e utilização e composição correspondentes
CL2004000031A1 (es) Compuestos derivados de n-arilamidas de acidos sulfonilamino carboxilicos sustituidos con azufre; composicion farmaceutica; procedimiento de preparacion; y uso del compuesto para tratar la hipertension, angina de pecho, restenosis, infarto al miocard
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
DE69940171D1 (de) Zwischenprodukte zur Herstellung von anti-thrombotischen 4H-Cyclopenta-1,3-dioxol-Derivaten
DK1007009T3 (da) Farmaceutisk sammensætning med to overtrækslag
CO5231229A1 (es) Composiciones a base de disulfuro de dimetilo color enmascarado
ID29950A (id) Bahan-bahan karbon amorf gabungan, pembuatan dan penggunaannya
BR9714002A (pt) Pirróis como inibidores de spla2
BR9900320A (pt) Composição antimicrobiana
BR9804437A (pt) Compostos para a osteoporose
PT996430E (pt) Composicoes de analogos nucleotidicos
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
BR9807714A (pt) Processo para a fabricação de corpos compostos de cerâmica-metal, corpos compostos de cerâmica-metal e seu emprego
BRPI0417948A (pt) derivados de quinuclidina substituìda por bicicloheterociclo fundido
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
BR9815747A (pt) Composição para liberação de aroma
BR9808140A (pt) Formulação unitária
ES2091324T3 (es) Proceso para la preparacion de aspartama a partir de una dicetopiperazina y nuevos compuestos intermedios y derivados para dicho proceso.
BR9810703A (pt) Composição farmacêutica, e, processos para a preparação da mesma, e para tratar um distúrbio de agregação de plaqueta
BR9901275A (pt) Triciclicos substituidos.
IT8947756A0 (it) Forme di somministrazione solide, che si decompongono rapidamente, relativo procedimento di produzione e loro impiego
GB2380939B (en) Treatment or prevention of auto-immune diseases
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
FR2805456B1 (fr) Prothese totale de genou, du type dit &#34;postero-stabilisee&#34;

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: LABORATORIOS VITA, S.A. (ES)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007.